moneycontrol.com11y
Fresenius Kabi
In December 2014, Fresenius Kabi had filed a suit against Claris Lifesciences to block commercialisation of its abbreviated new drug application (ANDA) for Propofol, used to induce or maintain ...
Drug Store News1mon
Fresenius inks licensing agreement to commercialize proposed Aflibercept biosimilar
Fresenius, through its operating company Fresenius Kabi, is broadening its growing biopharma portfolio through a new licensing agreement with South Korea’s SamChunDang Pharm. Under the agreement ...
TMCnet10d
Fresenius Kabi Receives FDA 510(k) Clearance for Adaptive Nomogram, Enhancing Plasma Collection Efficiency with the Aurora Xi Plasmapheresis System
Plasma-derived therapies are essential for treating a wide range of conditions, including immune deficiencies, bleeding ...
Contract Pharma10d
FDA Grants 510(k) Clearance for Fresenius Kabi’s Adaptive Nomogram
The U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance for Fresenius Kabi’s Adaptive Nomogram, an ...
moneycontrol.com6y
Fresenius Kabi Oncology
Fresenius Kabi standalone Dec '13 sales at Rs 84.66 crore Fresenius Kabi Oncology has reported a standalone sales turnover of Rs 84.66 crore and a net loss of Rs 63.63 crore for the quarter ended ...